
384: Live from the JP Morgan conference, a sit-down with Novo Nordisk's CEO and VC Bob Nelsen
The Readout Loud
00:00
Metsera pursuit and acquisition discipline
Mike explains Novo's disciplined $10B bidding on Metsera and rationale behind valuation limits.
Play episode from 12:48
Transcript


